GEODE CAPITAL MANAGEMENT, LLC - HORIZON PHARMA PLC ownership

HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 192 filers reported holding HORIZON PHARMA PLC in Q2 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of HORIZON PHARMA PLC
ValueSharesWeighting
Q1 2019$59,294,000
-21.6%
2,243,447
-42.0%
0.02%
+25.0%
Q4 2018$75,636,000
+117.4%
3,870,914
+117.8%
0.01%
+20.0%
Q3 2018$34,795,000
+17.9%
1,777,115
-0.2%
0.01%
+11.1%
Q2 2018$29,501,000
+28.0%
1,781,485
+9.7%
0.01%
+12.5%
Q1 2018$23,051,000
+4.4%
1,623,367
+7.3%
0.01%0.0%
Q4 2017$22,087,000
+17.0%
1,512,858
+1.6%
0.01%
+14.3%
Q3 2017$18,879,000
+11.8%
1,488,908
+4.6%
0.01%0.0%
Q2 2017$16,889,000
-17.2%
1,422,845
+3.1%
0.01%
-12.5%
Q1 2017$20,389,000
-8.0%
1,379,581
+0.7%
0.01%
-20.0%
Q4 2016$22,167,000
+2.0%
1,370,105
+14.3%
0.01%
-9.1%
Q3 2016$21,733,000
+19.5%
1,198,744
+8.5%
0.01%
+10.0%
Q2 2016$18,194,000
+32.0%
1,104,758
+32.8%
0.01%
+42.9%
Q1 2016$13,785,000
-20.8%
831,978
+3.6%
0.01%
-30.0%
Q4 2015$17,404,000
+14.2%
803,143
+4.4%
0.01%
+11.1%
Q3 2015$15,243,000
-42.6%
769,089
+0.6%
0.01%
-40.0%
Q2 2015$26,565,000
+120.5%
764,691
+64.8%
0.02%
+114.3%
Q1 2015$12,048,000
+131.5%
463,955
+14.9%
0.01%
+133.3%
Q4 2014$5,205,000
+17.5%
403,816
+11.9%
0.00%0.0%
Q3 2014$4,429,000360,7430.00%
Other shareholders
HORIZON PHARMA PLC shareholders Q2 2017
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,609,894$109,460,0003.84%
Avoro Capital Advisors LLC 5,593,683$92,631,0003.57%
Broadfin Capital, LLC 1,339,575$22,183,0003.49%
SCOPIA CAPITAL MANAGEMENT LP 11,912,290$197,268,0003.45%
JW Asset Management, LLC 270,775$4,484,0002.86%
Rhenman & Partners Asset Management AB 1,632,212$27,029,0002.77%
Paulson & Co. 7,670,700$127,027,0002.60%
Redwood Investments, LLC 1,315,149$21,779,0001.50%
KOPP INVESTMENT ADVISORS LLC 93,220$1,544,0001.45%
1492 Capital Management LLC 72,951$1,208,0000.86%
View complete list of HORIZON PHARMA PLC shareholders